Search Results

You are looking at 31 - 40 of 71 items for :

  • autoimmunity x
Clear All
Open access

Ya-Fen Hu, Lin Hua, Xiu Tuo, Ting-Ting Shi, Yi-Lin Yang, Yun-Fu Liu, Zhong-Yu Yan and Zhong Xin

. Autoimmunity in Graves’ ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? Journal of Clinical Endocrinology and Metabolism 2011 96 2386 – 2394 . ( ) 14 Yin X Latif

Open access

Yongping Liu, Shuo Wang, Qingling Guo, Yongze Li, Jing Qin, Na Zhao, Yushu Li, Zhongyan Shan and Weiping Teng

) 10.1056/NEJM199607113350206 3 Pan XF Gu JQ Shan ZY. The prevalence of thyroid autoimmunity in patients with urticaria: a systematic review and meta-analysis . Endocrine 2015 48 804 – 810 . ( doi:10.1007/s12020-014-0367-y ) 10

Open access

Paolo G Arduino, Dora Karimi, Federico Tirone, Veronica Sciannameo, Fulvio Ricceri, Marco Cabras, Alessio Gambino, Davide Conrotto, Stefano Salzano, Mario Carbone and Roberto Broccoletti

235 – 243 . ( doi:10.1111/j.1601-0825.2009.01516.x ) 10.1111/j.1601-0825.2009.01516.x 19222766 2 Mustafa MB Porter SR Smoller BR Sitaru C. Oral mucosal manifestations of autoimmune skin diseases . Autoimmunity Reviews 2015 14

Open access

Adriano N Cury, Verônica T Meira, Osmar Monte, Marília Marone, Nilza M Scalissi, Cristiane Kochi, Luís E P Calliari and Carlos A Longui

tremendous controversy regarding the most appropriate treatment schedule for this age group (3) . No strategy targets the underlying autoimmunity, and the control of thyroid hyperfunction is usually achieved by the induction of hypothyroidism. In many

Open access

C E Higham, A Olsson-Brown, P Carroll, T Cooksley, J Larkin, P Lorigan, D Morganstein, P J Trainer and the Society for Endocrinology Clinical Committee

A Becker C. Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy . European Journal of Endocrinology 2011 164 303 – 307 . ( ) 21088057 10.1530/EJE-10-0833 13 Orlov S Salari

Open access

Xuhua Mao, Hucheng Chen, Junmin Tang, Liangliang Wang and Tingting Shu

important role in the development of β-cell dysfunction. Many factors are known to inhibit insulin synthesis, including lipotoxicity, autoimmunity, inflammation, adipokines ( 2 , 3 ) and gluco-toxicity, which is caused by chronic exposure to abnormally high

Open access

W Liu, Y Wang, X Han, X Cai, Y Zhu, M Zhang, S Gong, J Li and L Ji

2017 32 – 42 . ( ) 12 Liu W Han X Wang Y Gong S Ma Y Zhang S Gao X Ji L . Characteristics and ongoing autoimmunity of patients with long-standing type 1 diabetes living in China

Open access

Aleksandra Krygier, Ewelina Szczepanek-Parulska, Dorota Filipowicz and Marek Ruchała

autoimmune thyroid disease (AITD) in children . Autoimmunity 2014 47 466 – 472 . ( ) 23 Floriani C Feller M Aubert CE M'Rabet-Bensalah K Collet TH den Elzen WPJ Bauer DC Angelillo

Open access

Ingeborg Brønstad, Lars Breivik, Paal Methlie, Anette S B Wolff, Eirik Bratland, Ingrid Nermoen, Kristian Løvås and Eystein S Husebye

P450 21-hydroxylase: the major autoantigen in autoimmune Addison's disease . Journal of Autoimmunity 2009 33 58 – 67 . ( doi:10.1016/j.jaut.2009.02.018 ). 14 Methlie P Hustad SS Kellmann R Almas B Erichsen MM Husebye E Lovas K

Open access

Maryam Iravani, Marie K Lagerquist, Elham Karimian, Andrei S Chagin, Claes Ohlsson and Lars Sävendahl

GPER1 has also been reported in human stem cells ( 7 ). In addition to the physiological effects, GPER1 might be involved in various estradiol (E2)-dependent diseases, such as atherosclerosis, osteoporosis, autoimmunity and tumors of the reproductive